| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/25/2011 | US20110207914 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 08/25/2011 | US20110207913 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 08/25/2011 | US20110207912 Fgf-19 nucleic acids |
| 08/25/2011 | US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage |
| 08/25/2011 | US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response |
| 08/25/2011 | US20110207679 Methods of treatment using il-16 antagonist peptides |
| 08/25/2011 | US20110207678 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 08/25/2011 | US20110207676 Glycosylation of Molecules |
| 08/25/2011 | US20110207671 Method for producing double-crosslinked collagen |
| 08/25/2011 | US20110207670 Compositions and methods of use for soluble thrombomodulin variants |
| 08/25/2011 | US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
| 08/25/2011 | US20110207668 Binding proteins inhibiting the vegf-a receptor interaction |
| 08/25/2011 | US20110207667 Efficient expression of truncated human rnaset2 in e. coli |
| 08/25/2011 | US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 08/25/2011 | US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof |
| 08/25/2011 | US20110207662 Composition for Long-Acting Peptide Analogs |
| 08/25/2011 | US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS |
| 08/25/2011 | US20110207212 T1r taste receptors and genes encoding same |
| 08/25/2011 | US20110207211 Expression of immunoglobulin-cytokine fusion proteins in malignant b cells |
| 08/25/2011 | US20110207195 Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
| 08/25/2011 | US20110207154 Method for determination of marinobufagenin levels and compounds employable in such method |
| 08/25/2011 | US20110207148 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/25/2011 | US20110207133 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 08/25/2011 | US20110207130 Method of detecting tumor-associated hypermethylated DNA in plasma or serum |
| 08/25/2011 | US20110206760 Angiopoietin derived peptides |
| 08/25/2011 | US20110206759 Ccr7 ligand delivery and co-delivery in immunotherapy |
| 08/25/2011 | US20110206757 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 08/25/2011 | US20110206755 Methods and products for manipulating uncoupling protein expression |
| 08/25/2011 | US20110206736 Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same |
| 08/25/2011 | US20110206733 Immunizing Compositions and Methods of Use |
| 08/25/2011 | US20110206730 Dengue Chimeric Viruses |
| 08/25/2011 | US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 08/25/2011 | US20110206714 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 08/25/2011 | US20110206713 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 08/25/2011 | US20110206710 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/25/2011 | US20110206692 Conformers of bacterial adhesins |
| 08/25/2011 | US20110206685 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 08/25/2011 | US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 08/25/2011 | US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 08/25/2011 | US20110206676 Compositions and methods related to staphylococcal bacterium proteins |
| 08/25/2011 | US20110206674 Yersinia SPP. Polypeptides and Methods of Use |
| 08/25/2011 | US20110206668 Methods and compositions for modulating immunity |
| 08/25/2011 | US20110206633 Polymer conjugates of cd-np peptides |
| 08/25/2011 | US20110206618 Fluorescent labeling material and flourescent labeling agent |
| 08/25/2011 | US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery |
| 08/25/2011 | US20110206611 DNA Dendrimers as Thermal Ablation Devices |
| 08/25/2011 | US20110206605 Molecular Probe for Imaging of Pancreatic Islets and Use of the Same |
| 08/25/2011 | CA2790487A1 Novel ctla4-ig immunoadhesins |
| 08/25/2011 | CA2790329A1 Fibronectin based scaffold domain proteins that bind il-23 |
| 08/25/2011 | CA2790029A1 Axmi221z, axmi222z, axmi223z, axmi224z, and axmi225z delta-endotoxin genes and methods for their use |
| 08/25/2011 | CA2789492A1 Disulphide bond-stabilized functional soluble mhc class ii heterodimers |
| 08/25/2011 | CA2789337A1 Hsa-related compositions and methods of use |
| 08/25/2011 | CA2789244A1 Rage fusion protein compositions and methods of use |
| 08/25/2011 | CA2784211A1 Neuregulin antagonists and use thereof in treating cancer |
| 08/25/2011 | CA2782448A1 Compositions and methods for the detection of antibodies to native human leukocyte antigen |
| 08/24/2011 | EP2360261A1 Collagen producing plants and methods of generating and using same |
| 08/24/2011 | EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis |
| 08/24/2011 | EP2360259A2 Promyostatin peptides and methods of using same |
| 08/24/2011 | EP2360258A2 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2011 | EP2360257A2 Hepatitis B virus (HBV) variants |
| 08/24/2011 | EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof |
| 08/24/2011 | EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs |
| 08/24/2011 | EP2360248A1 Ply-GBS mutant lysins |
| 08/24/2011 | EP2360243A1 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same |
| 08/24/2011 | EP2360181A1 IL-21 variants |
| 08/24/2011 | EP2360180A2 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 08/24/2011 | EP2360179A1 Novel bacillus thuringiensis insecticidal proteins |
| 08/24/2011 | EP2360178A1 Novel organic solvent lipase gene |
| 08/24/2011 | EP2360177A1 Klebsiella antigens |
| 08/24/2011 | EP2360176A2 Hybrid and tandem expression of neisserial derived proteins |
| 08/24/2011 | EP2360175A2 Norovirus and Sapovirus virus-like particles (VLPs) |
| 08/24/2011 | EP2360174A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 08/24/2011 | EP2360173A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof |
| 08/24/2011 | EP2360172A2 Bipodal peptide binder |
| 08/24/2011 | EP2360171A1 Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest |
| 08/24/2011 | EP2360170A2 Selective reduction and derivatization of engineered proteins comprinsing at least one non-native cysteine |
| 08/24/2011 | EP2360169A2 PSMA antibodies |
| 08/24/2011 | EP2360168A1 Flavivirus fusion inhibitors |
| 08/24/2011 | EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor |
| 08/24/2011 | EP2359868A1 Vector encoding human globulin gene and use thereof in treatment of hemoglobinopathies |
| 08/24/2011 | EP2359864A2 Targeting Vector-Phospholipid Conjugates |
| 08/24/2011 | EP2359863A2 Isolation and use of solid tumor stem cells |
| 08/24/2011 | EP2359857A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 08/24/2011 | EP2359851A2 MVA expressing modified hiv envelope, gag, and pol genes |
| 08/24/2011 | EP2359848A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 08/24/2011 | EP2359847A1 Modulation of beta-amyloid levels by beta-secretase bace2 |
| 08/24/2011 | EP2359841A2 Survivin-derived peptides and use thereof |
| 08/24/2011 | EP2359685A1 Methods to engineer mammalian-type carbohydrate structures |
| 08/24/2011 | EP2358893A2 Method for producing riboflavin |
| 08/24/2011 | EP2358881A1 Expression cassettes for seed-enhanced expression in plants |
| 08/24/2011 | EP2358880A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
| 08/24/2011 | EP2358879A2 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof |
| 08/24/2011 | EP2358837A1 Composition comprising a hydrophobin for gluing paper products |
| 08/24/2011 | EP2358752A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1 |
| 08/24/2011 | EP2358751A1 Truncated cd20 protein, deltacd20 |
| 08/24/2011 | EP2358750A2 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels |
| 08/24/2011 | EP2358749A2 Fgf21 mutants and uses thereof |
| 08/24/2011 | EP2358748A2 Methods and compositions for specific modulation of mcl-1 |
| 08/24/2011 | EP2358747A1 Bms1 protein expression system |
| 08/24/2011 | EP2358746A1 Binding proteins inhibiting the vegf-a receptor interaction |